Nanoviricides Inc (NNVC)
1.28
-0.05
(-3.76%)
USD |
NYAM |
Nov 21, 16:00
1.285
0.00 (0.00%)
After-Hours: 20:00
Nanoviricides Enterprise Value: 14.50M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 14.50M |
| November 20, 2024 | 15.22M |
| November 19, 2024 | 15.79M |
| November 18, 2024 | 14.64M |
| November 15, 2024 | 13.78M |
| November 14, 2024 | 15.36M |
| November 13, 2024 | 14.96M |
| November 12, 2024 | 14.96M |
| November 11, 2024 | 15.66M |
| November 08, 2024 | 16.22M |
| November 07, 2024 | 16.91M |
| November 06, 2024 | 16.49M |
| November 05, 2024 | 17.05M |
| November 04, 2024 | 16.63M |
| November 01, 2024 | 15.94M |
| October 31, 2024 | 16.08M |
| October 30, 2024 | 15.10M |
| October 29, 2024 | 16.22M |
| October 28, 2024 | 17.33M |
| October 25, 2024 | 16.98M |
| October 24, 2024 | 16.91M |
| October 23, 2024 | 16.77M |
| October 22, 2024 | 17.05M |
| October 21, 2024 | 16.63M |
| October 18, 2024 | 16.77M |
| Date | Value |
|---|---|
| October 17, 2024 | 16.91M |
| October 16, 2024 | 17.19M |
| October 15, 2024 | 17.05M |
| October 14, 2024 | 16.08M |
| October 11, 2024 | 16.91M |
| October 10, 2024 | 15.24M |
| October 09, 2024 | 15.38M |
| October 08, 2024 | 16.10M |
| October 07, 2024 | 15.40M |
| October 04, 2024 | 16.81M |
| October 03, 2024 | 15.96M |
| October 02, 2024 | 17.09M |
| October 01, 2024 | 16.67M |
| September 30, 2024 | 17.23M |
| September 27, 2024 | 16.48M |
| September 26, 2024 | 13.87M |
| September 25, 2024 | 12.95M |
| September 24, 2024 | 14.26M |
| September 23, 2024 | 15.44M |
| September 20, 2024 | 15.84M |
| September 19, 2024 | 15.97M |
| September 18, 2024 | 17.02M |
| September 17, 2024 | 16.10M |
| September 16, 2024 | 14.92M |
| September 13, 2024 | 16.36M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-2.466M
Minimum
May 12 2022
124.76M
Maximum
Jan 31 2020
19.78M
Average
15.28M
Median
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.798M |
| Palatin Technologies Inc | 15.96M |
| iBio Inc | 12.31M |
| Theriva Biologics Inc | -12.68M |
| Oragenics Inc | 2.273M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.127M |
| Total Expenses (Quarterly) | 3.168M |
| EPS Diluted (Quarterly) | -0.23 |
| Earnings Yield | -59.38% |